CMS has successfully represented interests of GE Healthcare in several court proceedings against the Russian healthcare regulatory authority (Roszdravnadzor). We could invalidate the regulator’s refusal from registering one of GE Healthcare products, modern ultrasound diagnostic system, in Russia. The positive decision of the court of first instance has been awarded in July 2020 and the regulator is bound to authorise the client’s product and allow its circulation in Russia.
This case is specific since it is a very rare precedent in Russia when a major medical device manufacturer decides to appeal a decision of the healthcare authority.
Vsevolod Tyupa, Head of Life Sciences at CMS Russia, led the team and was supported by the senior associate Igor Sokolov and associates Alexey Shadrin and Anastasia Entyakova.